The Alkaline Phosphatase Flare Phenomenon: A Transient Substantial Increase in Alkaline Phosphatase Concentration in a Prostate Cancer Patient after Starting GnRH Agonist Treatment
A 78-year-old man with metastatic prostate cancer was referred to the hospital 5 weeks after the initiation of systemic therapy with goserelin (GnRH agonist) because of a significant increase in alkaline phosphatase (ALP) concentration despite clinical improvement. Further workup revealed a decrease...
Main Authors: | Pierina Merlo, Christoph Rochlitz, Michael Osthoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-02-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/513427 |
Similar Items
-
Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
by: Maryam Eftekhar, et al.
Published: (2013-01-01) -
Mini-dose long gonadotropin-releasing hormone (GnRH) agonist versus agonist flare stimulation protocol for in vitro fertilization poor responders
by: Mona Mohamed Shaban
Published: (2014-12-01) -
Absence of PSA Flare With Apalutamide Administered 1 Hour in Advance With GnRH Agonists: Case Report
by: Zhiquan Hu, et al.
Published: (2022-05-01) -
Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist
by: Nayereh Khadem Ghaebi, et al.
Published: (2018-11-01) -
Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
by: Zakia Mahdy Ibrahim, et al.
Published: (2011-12-01)